Candesartan HCT Zentiva 32/12.5mg, Tabletten - 28 Swissmedic Key 62321017 Registration Holder Helvepharm AG Name Candesartan HCT Zentiva 32/12.5mg, Tabletten Date of registration 30.01.2012 Original/Generic Generic Introduction of Sequence 02.12.2013 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 28 Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 11.01 Limitation No Deductible 10 % Consumer price 28.35 Feedback FB GTIN 7680623210173 Medication Code Synthetika Pharmacode Disponibility ●
Composition candesartanum cilexetilum 32 mg, hydrochlorothiazidum 12.5 mg, mannitolum 138.4 mg, maydis amylum, copovidonum, glycerolum 13 mg, magnesii stearas, E 172 (flavum), pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose additional_information (Flavum) Copovidonum E 172 color. Glycerol 13 mg Magnesii Stearas Mannitol 138.4 mg Maydis Amylum Pro Compresso
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
